Erlotinib related compound A

SL-9440

Erlotinib related compound A, >98%

CAS No. : [299912-60-0]

IUPAC Name : 4-(3-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)-2-methylbut-3-yn-2-ol

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an analog or impurity of Erlotinib, which is a potent, selective inhibitor of EGFR. Erlotinib is a targeted therapeutic agent indicated for the treatment of specific malignancies, most notably non-small cell lung cancer (NSCLC) and pancreatic cancer.

References : Ng S. S. et al.: Mol Cancer Ther., 1(10), 777-783, 2002; Moyer J. D. et al. Cancer Res., 57(21), 4838-48, 1997; Pollack V. A. et al.: J. Pharmacol Exp Ther., 291(2), 739-748, 1999.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.